RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, July 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. RxSight reported its Q2 2025 financial results on July 9, 2025. The Company revealed declines in Light Delivery Devices ("LDD") sales and light adjustable intraocular lenses ("LAL") utilization, along with an overall revenue decline. The Company lowered its guidance for full year 2025, claiming that "Adoption challenges over the last few quarters have been a primary reason for the LDD stall." Based on this news, shares of RxSight fell by 37.8% on July 9, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm 
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com

View original content:https://www.prnewswire.com/news-releases/rxst-investors-have-opportunity-to-join-rxsight-inc-fraud-investigation-with-the-schall-law-firm-302509329.html

SOURCE The Schall Law Firm